Turnstone Communications

Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia

Diepenbeek, Belgium, 15 November 2022 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, […] November 15, 2022 · Turnstone Communications

Is Belgium becoming a hub for gene therapy?

Ghent, Belgium, 10 November 2022 ­– Gene therapy provides solutions to deadly diseases. Is the technology ready for a big […] November 10, 2022 · Turnstone Communications

Intressa Vascular secures EUR 18 million in financing to support the development of its multilayer Allay™ Aortic Stent for the treatment of aortic dissection

Intressa Vascular is using its proprietary stent braiding technology to develop an innovative multilayer stent for the treatment of aortic […] October 25, 2022 · Turnstone Communications

NeuVasQ Appoints Former UCB Ventures VP and Partner Emmanuel Lacroix as Chief Executive Officer and Expands Its Board of Directors

Gosselies, Belgium, 15 September 2022 – NeuVasQ Biotechnologies, a ULB spin-off developing pharmaceuticals to restore blood-brain barrier function, announces the […] September 20, 2022 · Turnstone Communications

New program fulfills the need for entrepreneurial talent in the life sciences

The vibrant Belgian life sciences sector needs a constant influx of young and ambitious entrepreneurs to sustain its growth. The […] June 22, 2022 · Turnstone Communications

Belgian stakeholders make recommendations for urgently needed data science strategy in healthcare

Antwerp, Belgium, 21 June 2022 – Inovigate, a consulting company for the healthcare industry, together with the Belgian Association of […] June 21, 2022 · Turnstone Communications

Belgian stakeholders unite to strive for data science integration in healthcare

Data science is booming, including in the healthcare sector. However, in order to extract insights and benefits from our health […] June 15, 2022 · Turnstone Communications

Spearhead cluster flanders.healthTech turns into MEDVIA and is ready to make a change in healthcare innovation

Ghent, Belgium, 17 May 2022 – With a strong new name and a sleek website, the industry-driven network MEDVIA aims at […] May 17, 2022 · Turnstone Communications

Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions

Diepenbeek, Belgium, 12 May 2022 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, appoints […] May 12, 2022 · Turnstone Communications

Augustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications

Leuven, Belgium, 10 May 2022 – Augustine Therapeutics, a biotech company developing novel therapies for neuromuscular and neurodegenerative disorders, appoints […] May 10, 2022 · Turnstone Communications

miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test

Leuven, Belgium, 2 May 2022 – miDiagnostics, a fast-growing POC diagnostics company announces the launch of its CE-IVD certified ultra-fast COVID-19 PCR […] May 2, 2022 · Turnstone Communications

Christine Durinx joins VIB as co-managing director

Belgium, 20 April 2022 – VIB and Flemish Minister of Economy and Innovation Hilde Crevits announce the appointment of Dr […] April 20, 2022 · Turnstone Communications

Solvay Brussels School of Economics and Management joins forces with the Belgian life sciences ecosystem to train the next generation of Biotech and MedTech leaders

Brussels, Belgium, 31 March 2022 — Today, the Solvay Brussels School of Economics and Management in collaboration with the ULB […] March 31, 2022 · Turnstone Communications

miDiagnostics welcomes Nicolas De Clercq as its new Chief Financial Officer

Leuven, Belgium, 30 March 2022 – miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces today that Nicolas De […] March 30, 2022 · Turnstone Communications

Rejuvenate Biomed Started a Groundbreaking Clinical Trial and Expands for Future Growth

 • Started clinical trial with lead candidate RJx-01 for treating sarcopenia  • Expands the team and moved to new offices and lab Diepenbeek, […] March 29, 2022 · Turnstone Communications

New incubator biotope by VIB launches to support biotech startup teams on their journey to success

Ghent, Belgium, 24 March 2022 – Incubator program biotope by VIB launches today to support biotech startup teams looking to impact people’s lives through […] March 24, 2022 · Turnstone Communications

Qbic announces first close of new fund at EUR 49 million to invest in spin-offs from world-class knowledge partners

St-Denijs-Westrem, Belgium, 17 March 2022 – Qbic, an inter-university venture capital fund focusing on the transformation of technological breakthroughs into […] March 17, 2022 · Turnstone Communications

flanders.healthTech launches 14 unique innovation projects in healthcare

Ghent, Belgium, 10 March 2022 – Following the launch of the cluster flanders.healthTech in 2021, the first round of 14 […] March 10, 2022 · Turnstone Communications

miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study

Leuven, Belgium, 17 February 2022 – miDiagnostics, a fast-growing POC diagnostics company backed by Belgian Family Offices, announces the success of the […] February 17, 2022 · Turnstone Communications

Newton Biocapital launches a new fund with initial capital commitments of EUR 50 million and target size of EUR 150 million

Brussels, Belgium, 15 February 2022 – Newton Biocapital (“Newton”), a life sciences investor, announces the launch of its new fund […] February 15, 2022 · Turnstone Communications

Ann Van Gysel appointed CEO of flanders.healthTech

Ghent, Belgium, 20 January 2022 – Dr. Ann Van Gysel has been appointed as CEO of the flanders.healthTech spearhead cluster. […] January 25, 2022 · Turnstone Communications

ElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer

Mechelen, Belgium, January 25, 2022 – Belgian company ElmediX is developing intensive and controlled heat treatments for the treatment of […] January 25, 2022 · Turnstone Communications

New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster

Ghent, Belgium, 6 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert […] December 6, 2021 · Turnstone Communications

Rejuvenate Biomed: Expanding peoples’ health spans by boosting cell resilience

Aging will affect each and every one of us at some point; it is part of the covenant of life. […] November 24, 2021 · Turnstone Communications

Belgium has all the ingredients to be a top country for data science in health – but we have to act now!

– Science for health will connect decisionmakers with researchers, clinicians, and company leaders on the topic of data science in healthcare – The event […] November 15, 2021 · Turnstone Communications

Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging

Heusden-Zolder, Belgium, Schlieren, Zürich, Switzerland, and Luxembourg, Grand Duchy of Luxembourg, 12 October 2021 – Rejuvenate Biomed NV (‘Rejuvenate’), a […] October 12, 2021 · Turnstone Communications

EsoBiotec ready to transform cell therapy cancer treatments

– EsoBiotec, a recently founded biotech company, announces a EUR 6 million pre-series A round comprised of non-dilutive funding from […] September 30, 2021 · Turnstone Communications

A vision of the future: smart contact lenses to treat patients with iris disorders and light sensitivity

A woman opens her front door and looks to the sky to judge the weather. It’s sunny and inside her […] September 22, 2021 · Turnstone Communications

Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

Brussels, Belgium / Tokyo, Japan – 9 September 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] September 9, 2021 · Turnstone Communications

Spectricity Raises €14 Million Series B Funding as it Accelerates Plans to Deliver Industry Leading Hyperspectral Sensing to Mobile and Consumer Devices

Funding Expands Growth for Tiny Chip-size Sensors for Unimaginable New Applications. Mechelen, Belgium, August 3rd, 2021 – Spectricity, a leading provider of hyperspectral […] August 3, 2021 · Turnstone Communications

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

Ghent, Belgium, 14 July 2021 – Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO), in partnership with GHO Capital, […] July 14, 2021 · Turnstone Communications

Azalea Vision closes € 8 million Series A to develop a smart contact lens for light sensitivity and ocular disorders

Azalea Vision develops autonomous smart solutions embedded inside a contact lens to improve the quality of life of people with […] July 8, 2021 · Turnstone Communications

Newton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology

Brussels, Belgium / Tokyo, Japan – 1 July 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in […] July 1, 2021 · Turnstone Communications

Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy

 – Newton together with public and private investment partners invests in NeuVasQ for the development of blood-brain barrier pharmaceuticals based […] June 22, 2021 · Turnstone Communications

Montis Biosciences Awarded VLAIO Grant to Expand its Pipeline of Novel Immune-Oncology Therapeutics

Leuven, Belgium, 14 June 2021 – Montis Biosciences, a Belgium-based biotech company focused on the development of novel immuno-oncology therapeutics targeting the […] June 14, 2021 · Turnstone Communications

Ground-breaking Flemish health projects go virtual: Smart Hub Flemish Brabant launches Health Experience

Smart Hub Flemish Brabant has launched the innovative online platform ‘Health Experience’. The virtual tour gives exclusive insights into the […] May 18, 2021 · Turnstone Communications

Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski

Brussels, Belgium, 11 May 2021 – Droia Ventures today announced the final closing of its third fund, having raised EUR […] May 11, 2021 · Turnstone Communications

Pulsify Medical closes second round Series A funding of EUR 6.35 million for wearable ultrasound heart monitor patch

Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart. The company has announced […] May 4, 2021 · Turnstone Communications

Proteomics PharmaFluidics Launches Next Generation µPAC™ Technology for Routine Proteomics

Microfluidic chips for use in high-resolution nanoLC/MS workflows Ghent, Belgium, 27 April 2021 – PharmaFluidics NV, innovative life sciences instruments […] April 27, 2021 · Turnstone Communications

Augustine Therapeutics developing new medicines for neuromuscular diseases

Augustine Therapeutics had a lot of announcements this month: the VIB spin-off just appointed Dr. Sylvain Celanire as CEO, strengthened […] March 31, 2021 · Turnstone Communications

Montis Biosciences appoints René Hoet as Chief Scientific Officer

Leuven, Belgium, 31 March 2021 – MONTIS BIOSCIENCES, a discovery stage biotech company focused on the development of novel immuno-oncology therapeutics […] March 31, 2021 · Turnstone Communications

Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases

Leuven, Belgium, 23 March 2021 – Augustine Therapeutics, a biotech spin-out company from VIB that focuses on the development of […] March 23, 2021 · Turnstone Communications

Augustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board

Leuven, Belgium, 19th March 2021 – Augustine Therapeutics, a biotech company focused on the development of innovative medicines for rare […] March 19, 2021 · Turnstone Communications

Augustine Therapeutics appoints Sylvain Celanire as CEO to accelerate development of innovative medicines for rare neuromuscular diseases

Leuven, Belgium, 18th March 2021 – Augustine Therapeutics, a biotech company focused on the development of innovative medicines for rare […] March 18, 2021 · Turnstone Communications

Lessons learned from COVID-19: how do we prepare for the next pandemic?

Although the crisis has not yet passed, COVID-19 has already taught us many valuable lessons. This past year has tested […] March 10, 2021 · Turnstone Communications

Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products

Heusden-Zolder, Belgium, 2 March 2021 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing prescription drugs for age-related diseases, announces […] March 2, 2021 · Turnstone Communications

Newton Biocapital invests in Flemish start-up DeuterOncology

Brussels, Belgium, 24 February 2021 – Newton Biocapital I (“Newton Biocapital”), a life sciences investment fund active in Europe and […] February 24, 2021 · Turnstone Communications

Preventive saliva test for detecting the COVID-19 virus is now available to companies and organizations

Ghent, Belgium, 23 February 2021 – The Ghent company Biogazelle and the medical laboratory Labo Nuytinck (Ghent, Evergem), together with […] February 23, 2021 · Turnstone Communications

PharmaFluidics Announces Ultra-Sensitive Second Generation µPAC™ Technology for Unbiased Single Cell Proteomics

Micro-chip based µPAC™ LC columns – key component in Vienna IMP study measuring the proteome at picogram level Ghent, Belgium, […] February 17, 2021 · Turnstone Communications

Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center

– Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies – Seed investment by Swanbridge Capital and Van Herk […] February 8, 2021 · Turnstone Communications

DoseVue obtains CE Mark for its first in-vivo dosimetry product for radiation therapy

Diepenbeek, Belgium – January 28, 2021 – DoseVue NV, a privately held medical device company developing in-vivo dosimetry solutions for […] January 28, 2021 · Turnstone Communications

The rapid evolution of Chinese biotech

The world is smaller today than it has ever been. With the COVID-19 pandemic, we have seen the advantages of […] December 2, 2020 · Turnstone Communications

Belgian biotechs partnering with China: deals of 2020

In 2019, a delegation of Belgian biotechs participated in an economic mission to China led by H.R.H. Princess Astrid. Co-organized […] December 2, 2020 · Turnstone Communications

Long-term loyalty: A Belgian fund’s perspective on Chinese investors

Over the past few years, an increasing number of European biotechs have been signing deals with Chinese investors. The Chinese […] December 2, 2020 · Turnstone Communications

eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities

Niel, Belgium, 1 December 2020 – eTheRNA immunotherapies NV (“eTheRNA”) announced it has entered into a strategic cooperation and product […] December 2, 2020 · Turnstone Communications

Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers

Brussels, Belgium / Tokyo, Japan – 1 December 2020 – Newton Biocapital I (“Newton”), a life sciences investment fund active in Europe […] December 1, 2020 · Turnstone Communications

A bridge from East to West: linking Chinese and European biotech

There are two main reasons why a European company might want to establish official links with a Chinese investor: funding, […] December 1, 2020 · Turnstone Communications

Montis Biosciences appoints Karen Zinkewich-Péotti as Chief Executive Officer

Leuven, Belgium, 29 September 2020 – Montis Biosciences, a discovery stage biotech company focused on novel immuno-oncology therapeutics targeting the […] September 29, 2020 · Turnstone Communications

Belgian stem cell company GST bought by German pharmaceutical giant

The German pharmaceutical giant Boehringer Ingelheim has acquired GST, a stem cell specialist based in Belgium. A part of the […] August 31, 2020 · Turnstone Communications

Newton Biocapital I invests in J-Pharma Co., Ltd. in Japan focusing on drug development targeting L-type Amino Acid Transporter 1 (LAT1) for cancer and autoimmune diseases

Brussels, Belgium / Tokyo, Japan – 27 August 2020 – Newton Biocapital I (“Newton”), an investment company in life sciences, […] August 27, 2020 · Turnstone Communications

Anacura, a Belgian biotech company, sells stem cell business to Boehringer Ingelheim

Ghent, Belgium, 27 July 2020 – GST, the stem cell specialist for horses and pets within the Anacura Group, has […] July 27, 2020 · Turnstone Communications

Building bigger for Belgium’s maturing biotech scene

Biotech is booming in Belgium. To support the evolving needs of this world-class ecosystem, the Mariën family initiated and are […] July 7, 2020 · Turnstone Communications

Max Planck researchers feed Proteome AI with PharmaFluidics technology

Micro-chip based µPAC™ LC columns – key component in NATURE study doubling the universe of known proteins across all kingdoms […] June 18, 2020 · Turnstone Communications

PharmaFluidics awarded VLAIO research grant

Funding will support product range extension of micro-chip based µPAC™ nano, capillary and microflow LC columns, and accelerated development of […] June 2, 2020 · Turnstone Communications

BioVox: the global network for Belgian life sciences turns five and launches a new website!

May 4, 2020 · Turnstone Communications

Biogazelle initiates large-scale testing of COVID-19 in Belgium

Ghent, Belgium, April 2, 2020 – Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. [...] April 2, 2020 · Turnstone Communications

ElmediX wants to stop coronavirus by heating patients in a controlled manner

Mechelen, Belgium, 24 March 2020 – The coronavirus has brought the whole world to a standstill. The Belgian company ElmediX wants to contain the virus with intensive [...] March 24, 2020 · Turnstone Communications

Montis Biosciences launched with €8.4 million seed financing and a novel approach to immuno-oncology

Montis Biosciences announces its launch with €8,4 million in seed financing from an international investor syndicate to investigate interactions between perivascular macrophages [...] February 20, 2020 · Turnstone Communications

Inari: shaking things up in the agriculture business

Inari Agriculture has been awarded the 2020 Newcomer of the Year Trophy by Flanders Investment & Trade (FIT). Inari (US) opened its first foreign R&D branch in Ghent’s biotech [...] February 12, 2020 · Turnstone Communications

PharmaFluidics announces product range extension for its µPACᵀᴹ chromatography chips to serve new biopharma markets

PharmaFluidics NV, an innovative player in the field of analytical chromatography, announces a product range extension into capillary flow rate liquid chromatography (capillary LC). [...] February 10, 2020 · Turnstone Communications

Pulsify Medical to develop a wearable heart monitor patch

Pulsify Medical, a joint imec and KU Leuven spin-off, has closed a seed funding round of €2.6 million. The investment, […] October 24, 2019 · Turnstone Communications

Ovizio Imaging Systems announces iLine F and BioConnect supply agreements with Celgene Corporation

Brussels, Belgium 22/10/2019 – Ovizio Imaging Systems, a company providing an innovative microscopic imaging technology to the bioprocessing market, today […] October 22, 2019 · Turnstone Communications

Prof. Matthias Mann joins PharmaFluidics Advisory Board

Ghent, Belgium – October 22, 2019 – PharmaFluidics NV, an innovative player in the field of proteomics with the unique high-resolution µPACTM micro-Chip chromatography products, is pleased to welcome Prof. Dr. Matthias Mann as member of its Advisory Board. October 22, 2019 · Turnstone Communications

Pulsify Medical, a joint imec and KU Leuven spin-off, closes first-round funding, led by imec.xpand

Pulsify Medical will develop wearable ultrasound patches for non-invasive, real time monitoring of physiological parameters inside the body Leuven, Belgium, […] October 14, 2019 · Turnstone Communications

WELBIO joins ranks with celebrities after a new bacterium is named after the institute

WELBIO has received a truly unique form of acknowledgement: a newly discovered bacterium has been named after the research institute. […] July 10, 2019 · Turnstone Communications

Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

Ghent, Belgium, and Dresden, Germany – 3 July 2019 – Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH […] July 3, 2019 · Turnstone Communications

The future of healthcare is digital

This month marked the crystal anniversary of the life sciences networking event Knowledge for Growth. The event was a huge […] May 29, 2019 · Turnstone Communications

Confo Therapeutics: the next Belgian biotech star?

Just days before KBC Securities’ “State of the Union” announcement on how well Belgian biotech has been faring in 2019, […] May 29, 2019 · Turnstone Communications

Holographic imaging technology shines a light on cells

Have you ever considered how scientists are able to count transparent cells in a see-through solution? Traditional methods involve dyes, microscopes, time and effort [...] April 9, 2019 · Turnstone Communications

From scientist to entrepreneur: how a Belgian chromatography company came to be

Pharmafluidics is a Belgian company rethinking the fundamentals of liquid chromatography. Introducing a fundamentally new type of stationary phase in […] February 12, 2019 · Turnstone Communications

AuXin Surgery Announces the Launch of its new CADISS System for Selective Dissection in Surgery

Louvain-la-Neuve, Belgium, 7 February 2019 – AuXin Surgery, a medical device company, announces that it has obtained CE Class III […] February 7, 2019 · Turnstone Communications

Inari’s agricultural revolution hits Europe with a new site in Ghent

Inari, a U.S. company revolutionizing agricultural R&D, have just opened up their first overseas office in Ghent, Belgium. Partnering with […] February 6, 2019 · Turnstone Communications

Pharmafluidics’ new product launch steers ‘on-a-chip’ separations of complex biological samples to new heights

PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way […] February 1, 2019 · Turnstone Communications

Avoiding the pitfalls of clinical development as a biotech

For many decades, the pharmaceutical industry was the sole driver of innovation in healthcare. The rapid expansion of knowledge has […] December 11, 2018 · Turnstone Communications

argenx signs billion-dollar deal with Janssen

Another Belgian biotech on the up and up: argenx just closed a billion-dollar deal with Janssen Pharmaceutica for their antibody […] December 4, 2018 · Turnstone Communications

Microbiome regulations from an EU start-up's perspective

Interested in the microbiome? So are we! Here’s a sneak-peek into S-Biomedic, one of the first microbiome start-ups in Belgium. […] November 9, 2018 · Turnstone Communications

Ghent knowledge hub growing strong

The Flemish life sciences ecosystem is stronger than ever. This expertise, in biotech and health, is plain to see in […] October 23, 2018 · Turnstone Communications

How CRISPR/Cas9 is improving drug development using zebrafish

CRISPR/Cas9 came to the attention of scientists everywhere over five years ago. Ever since it hit the main stage, the […] September 4, 2018 · Turnstone Communications

New beta cell antigens discovered in Type 1 diabetes

A study published just last week has unveiled several new antigens implicated in Type 1 diabetes. In an ongoing project, […] August 7, 2018 · Turnstone Communications

Curing hay fever - ASIT Biotech allergy vaccines

The sun is shining, the grass is green, but hay fever season is at its peak! Many people (myself included) will spend a lot of money on antihistamines and [...] June 12, 2018 · Turnstone Communications

TrinCE transfection wins pitch awards

The pitching session at Knowledge for Growth 2018 gave a select number of start-ups a chance to present their company […] June 5, 2018 · Turnstone Communications

CD3 as co-creator of drugs with academia and pharma

The Center for Drug Design and Discovery (CD3), based in Leuven, bridges the gap between innovative biomedical research emerging from […] May 28, 2018 · Turnstone Communications

Visualizing the deep with a drivable endoscope that crawls into the sinus anatomy!

Do you suffer from chronic sinusitis? 3NT Medical have developed a highly advanced endoscope that allows access, visualization and treatment […] May 28, 2018 · Turnstone Communications

Fishing for answers: screening drug cardiotoxicity using zebrafish

Rodents have a well-established place in history as our most common animal models. Even the word lab-rat has become so […] March 19, 2018 · Turnstone Communications

UCB psoriasis drug approved for use in mothers

The UCB core drug CIMZIA® has just been approved by European Medicines Agency (EMA) for use in pregnant and breastfeeding […] March 19, 2018 · Turnstone Communications

Imaging beta-cells for better diabetes treatment

One in eleven adults around the world has diabetes, according to figures published by the International Diabetes Federation (IDF) in […] March 18, 2018 · Turnstone Communications

Confo Therapeutics is awarded a EUR 1M grant to increase its screening capabilities

Confo Therapeutics announced today that it has received a €1 million grant from the Flemish Government through Flanders Innovation & […] February 20, 2018 · Turnstone Communications

The biggest killer after malaria - How to tackle RSV?

Respiratory syncytial virus (RSV) annually threatens many babies and there is currently no drug or vaccine to combat the disease. […] February 19, 2018 · Turnstone Communications

Rewind Therapeutics secures funding for Multiple Sclerosis research

Rewind Therapeutics, a privately held Belgian biotech company, completed a € 15.2 million Series A financing to develop novel re-myelinating […] January 11, 2018 · Turnstone Communications

reMYND brings in Novo Nordisk to develop diabetes therapy

reMYND entered into a license agreement to further develop novel treatments improving beta-cell health and insulin signalling with Novo Nordisk. […] January 11, 2018 · Turnstone Communications